Viewing Study NCT01348503


Ignite Creation Date: 2025-12-24 @ 7:36 PM
Ignite Modification Date: 2025-12-25 @ 5:17 PM
Study NCT ID: NCT01348503
Status: TERMINATED
Last Update Posted: 2015-08-31
First Post: 2011-05-04
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Lenalidomide in Combination With a Fixed Dose of Sorafenib for the Treatment of Hepatocellular Carcinoma
Sponsor: Indiana University School of Medicine
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module